-
-
-
-
-
-
-
Aytu BioScience (AYTU) Appoints Mark Oki as CFO
-
-
-
-
-
-
-
Aytu BioScience (AYTU) Issues First U.S. Patent Supporting Healight Ultraviolet-A Respiratory Catheter
-
-
-
-
-
-
-
Aytu BioPharma to Report Fourth Quarter and Full Year Fiscal 2021 Results and Provide Business Update on September 27, 2021
-
-
-
-
-
-
-
Aytu BioPharma Reports Fiscal Third Quarter 2021 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
Aytu BioScience Announces Close of Merger with Neos Therapeutics
-
-
-
-
-
-
-
Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders Related to Proposed Merger to Be Held on March 18, 2021
-
-
-
-
-
-
-
Aytu BioScience Increases Previously Announced Bought Deal Offering to $25.0 Million
-
922,460 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All